medigraphic.com
ISSN 2448-8909 (Print)

2022, Number 6

<< Back Next >>

Med Crit 2022; 36 (6)

Non-invasive methods of oxygenation in patients with COVID-19. Descriptive review

Martínez GEX, Morales SG, Segura MLE, De CVA

Language: Spanish
References: 30
Page: 378-386
PDF size: 224.79 Kb.


ABSTRACT

In December 2019, several people with pneumonia of unknown cause were linked to a seafood market in Wuhan, China. With the discovery of a new type of coronavirus and the initiation of the COVID-19 pandemic, the most common symptoms manifested by patients consists of a flu syndrome, the severe illness generally occurs one week after the onset of symptoms. The severity of the picture is characterized by dyspnea, tachypnea and decreased oxygen saturation. In Mexico there have been approximately 3'684,242 total cases and 279,104 total deaths from COVID-19, up to epidemiological week number 40, being one of the countries with the highest mortality at the international level, 5-10% of patients infected by SARS-CoV-2 virus will require management in the intensive care unit, with the need for supplemental oxygen, hospital mortality in Mexico has reached 73.7%. The limits of hypoxemia that indicate the need for oxygen therapy are an arterial partial pressure of oxygen (PaO2) less than 60 mmHg. It is necessary for the specialist in critical patients to know the different interfaces and modes of oxygen administration, the administration of oxygen in patients with COVID-19 and hypoxemic respiratory failure must be appropriate and pertinent.


REFERENCES

  1. Shapiro B, Peruzzi W, Kozlowski R. Manejo Clínico de los gases sanguíneos. Capítulo 11, paginas. Editorial Médica Panamericana. 5ª ed, 2004, pp. 109-136.

  2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine. N Engl J Med. 2020;382(8):727-733.

  3. Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383(25):2451-2460.

  4. Informe técnico diario COVID-19 México. 04/10/2021. Disponible ne: https://www.gob.mx/cms/uploads/attachment/file/671496/Comunicado_Tecnico_Diario_COVID-19_2021.10.04.pdf

  5. Ñamendys-Silva S, Gutiérrez A, Romero J. Hospital mortality in mechanically ventilated COVID-19 patients in México. Intensive Care Med. 2020;46(11):2086-2088.

  6. Joly BS, Siguret V, Veyradier A. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19. Intensive Care Med. 2020;46:1603-1606.

  7. Álvarez-Sala W. Neumología Clínica. Capítulo 93. Oxigenoterapia en la insuficiencia respiratoria. 2010, pp. 776-783.

  8. O'Driscoll BR, Howard LS, Earis J, Mak V. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017;72:i1-i90. doi: 10.1136/thoraxjnl-2016-209729.

  9. Montrief T, Ramzy M, Long B, Gottlieb M, Hercz D. COVID-19 respiratory support in the emergency department setting. Am J Emerg Med. 2020 Oct;38 (10):2160-2168.

  10. Kumar A, Sinha C, Kumar A, Kumari P, Kumar N, Kumar A, et al. Lowflow nasal oxygen supplementation in addition to nonrebreathing mask: An alternative to highflow nasal cannula oxygenation for acute hypoxemic COVID-19 patients in resource limited settings. Trends in Anaesthesia & Critical Care. 2021;38:24-25.

  11. Grieco DL, Maggiore SM, Roca O, Spinelli E, Patel BK, Thille AW, et al. Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS. Intensive Care Med. 2021;47(8):851-866.

  12. Winck JC, Ambrosino N. COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problems. Pulmonology. 2020;26(4):213-220.

  13. Cinesi GC, Peñuelas RÓ, Luján TM, Egea SC, Masa JJF, García FJ, et al. Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection. Med Intensiva. 2020;44(7):429-438.

  14. Wang Z, Wang Y, Yang Z, Wu H, Liang J, Liang H, et al. The use of non-invasive ventilation in COVID-19: a systematic review. Int J Infect Dis. 2021;106:254-261.

  15. Winck JC, Scala R. Non-invasive respiratory support paths in hospitalized patients with COVID-19: proposal of an algorithm. Pulmonology. 2021;27(4):305-312.

  16. Burton-Papp HC, Jackson AIR, Beecham R, Ferrari M, Nasim-Mohi M, Grocott MPW, et al. Conscious prone positioning during non-invasive ventilation in COVID-19 patients: experience from a single centre. F1000Research, 2020; 9: 859.

  17. Nishimura M. High-flow nasal cannula oxygen therapy in adults. J Intensive Care. 2015;3(1):15.

  18. Li J, Fink JB, Ehrmann S. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J. 2020;55(5):2000892.

  19. He G, Han Y, Fang Q, Zhou J, Shen J, Li T, et al. Clinical experience of high-flow nasal cannula oxygen therapy in severe COVID-19 patients. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020;49(2):232-239. Chinese.

  20. Chandel A, Patolia S, Brown AW, Collins AC, Sahjwani D, Khangoora V, et al. High-flow nasal cannula therapy in COVID-19: using the ROX index to predict success. Respir Care. 2021;66(6):909-919.

  21. Garner O, Dongarwar D, Salihu HM, Barrantes Perez JH, Abraham J, et al. Predictors of failure of high flow nasal cannula failure in acute hypoxemic respiratory failure due to COVID-19. Respir Med. 2021;185:106474.

  22. Mellado-Artigas R, Ferreyro BL, Angriman F, Hernández-Sanz M, Arruti E, Torres A, et al. High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure. Crit Care. 2021;25(1):58.

  23. Simioli F, Annunziata A, Polistina GE, Coppola A, Di Spirito V, Fiorentino G. The role of high flow nasal cannula in COVID-19 associated pneumomediastinum and pneumothorax. Healthcare (Basel). 2021;9(6):620.

  24. Grieco DL, Menga LS, Cesarano M, Rosà T, Spadaro S, Bitondo MM, et al. Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure. JAMA. 2021;325(17):1731-1743.

  25. Navalesi P, Maggiore SM. Positive end-expiratory pressure. In: Tobin MJ. Principles and practice of mechanical ventilation, 3rd ed.; Tobin, M.J., Ed.; McGraw Hill Medical: New York, NY, USA, 2013; pp. 253-302.

  26. Crimi C, Noto A, Princi P, Esquinas A, Nava S. A European survey of noninvasive ventilation practices. Eur Respir J. 2010;36:362-369.

  27. Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032-1038.

  28. Patroniti N, Foti G, Manfio A, Coppo A, Bellani G, et al. Head helmet versus face mask for non-invasive continuous positive airway pressure: a physiological study. Int Care Med. 2003;29:1680-1687.

  29. Esquinas RAM, Papadakos PJ, Carron M, Cosentini R, Chiumello D. Clinical review: Helmet and non-invasive mechanical ventilation in critically ill patients. Crit Care. 2013;17(2):223.

  30. Taccone P, Hess D, Caironi P, Bigatello LM. Continuous positive airway pressure delivered with a "helmet": effects on carbon dioxide rebreathing. Crit Care Med. 2004;32(10):2090-2096.




2020     |     www.medigraphic.com